BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34857874)

  • 1. KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth.
    Shimoda M; Lyu Y; Wang KH; Kumar A; Miura H; Meckler JF; Davis RR; Chantarasrivong C; Izumiya C; Tepper CG; Nakajima KI; Tuscano J; Barisone G; Izumiya Y
    Commun Biol; 2021 Dec; 4(1):1330. PubMed ID: 34857874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
    Li X; Chen S; Feng J; Deng H; Sun R
    J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Do─čanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 promotes cell proliferation through suppressing Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation in the infected B-lymphoma cells.
    Sun C; Guo Y; Zhou W; Xia C; Xing X; Chen J; Li X; Zhu H; Lu J
    Virus Res; 2020 Sep; 286():198066. PubMed ID: 32553609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
    Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
    J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation.
    Gwack Y; Baek HJ; Nakamura H; Lee SH; Meisterernst M; Roeder RG; Jung JU
    Mol Cell Biol; 2003 Mar; 23(6):2055-67. PubMed ID: 12612078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
    Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
    PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.
    Nakamura H; Lu M; Gwack Y; Souvlis J; Zeichner SL; Jung JU
    J Virol; 2003 Apr; 77(7):4205-20. PubMed ID: 12634378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D; Guasparri I; Cesarman E
    Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P.
    Zhu J; Trang P; Kim K; Zhou T; Deng H; Liu F
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9073-8. PubMed ID: 15184661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.